JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
1639
5. Pisanu A, Lecca D, Mulas G, et al. Dynamic changes in pro-
and anti-inflammatory cytokines in microglia after PPAR-c
agonist neuroprotective treatment in the MPTPp mouse
model of progressive Parkinson’s disease. Neurobiol Dis
2014;71:280–91.
6. Yan AJ, Cai GY, Xia WL, et al. Thromboxane A2 receptor
antagonist SQ29548 suppresses the LPS-induced release of
inflammatory cytokines in BV2 microglia cells via suppress-
ing MAPK and NF-jB signaling pathways. Mol Med Rep
2017;16:2491–6.
7. Nishioku T, Matsumoto J, Dohgu S, et al. Tumor necrosis fac-
tor-alpha mediates the blood-brain barrier dysfunction
induced by activated microglia in mouse brain microvascular
endothelial cells. J Pharmacol Sci 2010;112:251–4.
8. da Fonseca AC, Matias D, Garcia C, et al. The impact of
microglial activation on blood-brain barrier in brain diseases.
Front Cell Neurosci 2014;8:362.
9. Hou Y, Ryu CH, Park KY, et al. Effective combination of
human bone marrow mesenchymal stem cells and minocyc-
line in experimental autoimmune encephalomyelitis mice.
Stem Cell Res Ther 2013;4:77.
10. Yang Y, Salayandia VM, Thompson JF, et al. Attenuation of
acute stroke injury in rat brain by minocycline promotes
blood-brain barrier remodeling and alternative microglia/
and
6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one.
Med
Chem 2011;7:213–23.
20. Kirby AJ, Le LR, Maharlouie F, et al. Inhibition of retinoic
acid metabolising enzymes by 2-(4-aminophenylmethyl)-6-
hydroxy-3,4-dihydronaphthalen-1(2H)-one and related com-
pounds. J Enzyme Inhib Med Chem 2003;18:27–33.
21. Wang FL, Zhang RX, Cui Y, et al. Design, synthesis and bio-
logical evaluation of 3,4-dihydronaphthalen-1(2H)-one deriva-
tives as Bcl-2 inhibitors. Res Chem Intermed 2017;43:5933–42.
22. Barlow JW, Walsh JJ. Synthesis and evaluation of 4-amino-
3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell
stabilising and anti-inflammatory compounds. Eur J Med
Chem 2008;43:2891–900.
23. Ding Y, Ko MH, Pehar M, et al. Biochemical inhibition of the
acetyltransferases ATase1 and ATase2 reduces b-secretase
(BACE1) levels and Ab generation. J Biol Chem 2012;287:
8424–33.
24. Sun Y, Gao ZF, Wang CH, et al. Synthesis, crystal structures
and anti-inflammatory activity of fluorine-substituted 1,4,5,6-
tetrahydrobenzo[h]quinazolin-2-amine
Crystallogr C Struct Chem 2019;75:1157–65.
derivatives.
Acta
25. Coen DM, Schaffer PA. Antiherpesvirus drugs: a promising
spectrum of new drugs and drug targets. Nat Rev Drug
Discov 2003;2:278–88.
26. Egan WJ, Lauri G. Prediction of intestinal permeability. Adv
Drug Deliver Rev 2002;54:273–89.
27. Singh N, Pandey J, Tripathi RP. A natural aminosugar as orga-
nocatalyst for an ecofriendly direct aldol reaction of ketones
with aromatic aldehydes in water. Catal Comm 2008;9:743–6.
28. Li N, Xin WY, Yao BR, et al. Novel dissymmetric 3,5-bis(aryli-
dene)-4-piperidones as potential antitumor agents with bio-
logical evaluation in vitro and in vivo. Eur J Med Chem
2018;147:21–33.
29. Yao BR, Sun Y, Chen SL, et al. Dissymmetric pyridyl-substi-
tuted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma
agents by inhibiting NF-jB pathway activation. Eur J Med
Chem 2019;167:187–99.
30. Li N, Yao BY, Wang CH, et al. Synthesis, crystal structure and
activity evaluation of novel 3,4-dihydro-1-benzoxepin-5(2H)-
one derivatives as protein-tyrosine kinase (PTK) inhibitors.
Acta Crystallogr C Struct Chem 2017;73:1003–9.
31. Jiang CS, Zhuang CL, Zhu K, et al. Identification of a novel
small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective
effects on LPS-induced cardiomyopathy. J Enzyme Inhib
Med Chem 2018;33:833–41.
32. Gao CL, Hou GG, Liu J, et al. Synthesis and target identifica-
tion of benzoxepane derivatives as potential anti-neuroin-
flammatory agents for ischemic stroke. Angew. Chem. Int.
Ed. Engl 2020;59:2429–39.
macrophage
activation
during
recovery.
J
Neuroinflammation 2015;12:26.
11. Dai J, Zhang X, Li L, et al. Autophagy inhibition contributes
to ROS-producing NLRP3-dependent inflammasome activa-
tion and cytokine secretion in high glucose-induced macro-
phages. Cell Physiol Biochem 2017;43:247–56.
12. Lee E, Hwang I, Park S, et al. MPTP-driven NLRP3 inflamma-
some activation in microglia plays a central role in dopamin-
ergic neurodegeneration. Cell Death Differ 2019;26:213–28.
13. Ye Y, Jin T, Zhang X, et al. Meisoindigo protects against
focal cerebral ischemia-reperfusion injury by inhibiting
NLRP3 inflammasome activation and regulating microglia/
macrophage polarization via TLR4/NF-jB signaling pathway.
Front Cell Neurosci 2019;13:553.
ꢀ
14. Slusarczyk J, Trojan E, Głombik K, et al. Targeting the NLRP3
inflammasome-related pathways via tianeptine treatment-
suppressed microglia polarization to the M1 phenotype in
lipopolysaccharide-stimulated cultures. Int J Mol Sci 2018;19:
1965.
15. Aryanpour R, Pasbakhsh P, Zibara K, et al. Progesterone
therapy induces an M1 to M2 switch in microglia phenotype
and suppresses NLRP3 inflammasome in
a cuprizone-
induced demyelination mouse model. Int Immunopharmacol
2017;51:131–9.
16. Jha S, Srivastava SY, Brickey WJ, et al. The inflammasome
sensor, NLRP3, regulates CNS inflammation and demyelin-
ation via caspase-1 and interleukin-18. J Neurosci 2010;30:
15811–20.
17. Laudisi F, Spreafico R, Evrard M, et al. Cutting edge: The
NLRP3 inflammasome links complement-mediated inflamma-
tion and IL-1b release. J Immunol 2013;191:1006–10.
18. Zeng KW, Wang S, Dong X, et al. Sesquiterpene dimer (DSF-
52) from Artemisia argyi inhibits microglia-mediated neuro-
inflammation via suppression of NF-jB, JNK/p38 MAPKs and
Jak2/Stat3 signaling pathways. Phytomedicine 2014;21:
298–306.
€
33. Gouverneur V, Muller K. Fluorine in pharmaceutical and
medicinal chemistry. 2012.
34. Zhang LS, Chen Q, Hou GG, et al. Hydroxyl-substituted dou-
ble Schiff-base condensed 4-piperidone/cyclohexanones as
potential anticancer agents with biological evaluation. J
Enzyme Inhib Med Chem 2019;34:264–71.
35. Su CM, Hou GG, Wang CH, et al. Potential multifunctional
agents with anti-hepatoma and anti-inflammation properties
by inhibiting NF-rB activation. J Enzyme Inhib Med Chem
2019;34:1287–97.
36. Hou Y, Fu J, Sun S, et al. BDE-209 induces autophagy and
apoptosis via IRE1a/Akt/mTOR signaling pathway in human
umbilical vein endothelial cells. Environ Pollut 2019;253:
429–38.
19. Barlow JW, Zhang T, Woods O, et al. Novel mast cell-stabilis-
ing amine derivatives of 3,4 dihydronaphthalen-1(2H)-one